Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy
@article{TLCR41144,
author = {Kenichi Suda and Tetsuya Mitsudomi},
title = {Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy},
journal = {Translational Lung Cancer Research},
volume = {9},
number = {6},
year = {2020},
keywords = {},
abstract = {},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/41144}
}